CurrentColorado Rocky Mountain Health PlansPolicy 2026T0563X

Pneumatic Compression Devices

Defines medical policy coverage positions and clinical evidence summary for pneumatic compression devices (intermittent pneumatic compression, advanced APCDs, high-pressure devices) across indications including lymphedema (head/neck and limb), peripheral arterial disease, chronic venous insufficiency with nonhealing lower extremity ulcers, and prevention of deep venous thrombosis; references InterQual criteria for detailed medical necessity rules.

Policy Summary

PayerColorado Rocky Mountain Health Plans

PolicyPneumatic Compression Devices

Policy CodePolicy 2026T0563X

Change TypeRevised medical necessity language; references updated

Effective DateJune 1, 2026

Next Review Date

Key ActionWhen coverage is considered, refer to and document fulfillment of InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices clinical criteria.

POLICY UPDATE CHANGES

Revised language pertaining to medical necessity clinical coverage criteria.

Updated Clinical Evidence and References sections to reflect the most current information.

4Major Indication Statements (HNL, PAD, Lymphedema/VLU, DVT prevention)

multipleClinical studies cited

2876Large stroke RCT (CLOTS3)

Critically ill RCT (Arabi) participants

Coverage Summary

Pneumatic compression devices span simple intermittent pneumatic compression (IPC) sleeves to more complex, programmable advanced pneumatic compression devices (APCD) and high-pressure intermittent limb compression (HPIPC) systems. Primary indications addressed include treatment of lymphedema (including head/face/neck and limb), management of chronic venous insufficiency with edema and nonhealing lower‑extremity ulcers, prevention of deep venous thrombosis (DVT), and use in select patients with peripheral arterial disease (PAD). Detailed medical necessity rules and specific coverage determinations are delegated to InterQual; refer to InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices for the full clinical criteria and authorization requirements.

Policy metadata & IPC duration threshold example

effective_dateJune 1, 2026

policy_number2026T0563X

coverage_stancemixed (some indications proven/medically necessary; specific APCD and PAD uses unproven/not medically necessary)

scope_summaryDefines coverage positions and clinical evidence summary for pneumatic compression devices across indications including head/neck and limb lymphedema, peripheral arterial disease, chronic venous insufficiency with nonhealing lower extremity ulcers, and DVT prevention; references InterQual criteria for medical necessity.

IPC application duration (example from RCTs)examples: at least 18 hours/day (Arabi et al.); applied median 22 hours/day for median 7 days; CLOTS3 used IPC up to 30 days or until discharge/walking independently with mean duration ~11 days

Medical Necessity Criteria (delegated to InterQual)

Medical necessity determinations for pneumatic compression device coverage are delegated to InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices. Providers and payers should use the InterQual criteria to assess whether clinical coverage rules are met prior to approving or furnishing devices. (Evidence note: InterQual reference.)

Not Medically Necessary / Experimental

Systematic reviews and RCTs for APCDs in head/neck lymphedema and for HPIPC in PAD are limited and of low-to-moderate quality. For head/neck lymphedema, small trials and observational studies (including one RCT of APCDs and several uncontrolled reports) provide inconsistent, low‑quality evidence and do not establish efficacy or safety, leading to the policy position that APCDs for head/neck lymphedema are unproven and not medically necessary. For PAD, systematic reviews and small RCTs suggest possible improvements in walking distance, rest pain, or wound healing in select patients, but studies are heterogeneous, at risk of bias, and insufficient to support coverage of high-pressure devices for arterial insufficiency; therefore HPIPC for PAD is considered unproven and not medically necessary.

Clinical Evidence & Guideline Summary

This section summarizes the key randomized controlled trials and meta-analyses that inform coverage decisions. Selected high-quality trials (for example, CLOTS3 in stroke patients) and published systematic reviews/meta-analyses on IPC and related devices underpin the clinical evidence statements used in the policy.

Clinical Evidence Summary for IPC use (findings informing coverage)

Evidence-based findings and guideline-informing study results (each as separate evidence leaf nodes):

Arabi RCT (critically ill): In critically ill patients receiving pharmacological thromboprophylaxis, adjunctive IPC did not reduce proximal lower limb DVT compared with pharmacological prophylaxis alone (Arabi et al. RCT: RR 0.93; 95% CI 0.60-1.44; p=0.74).

IPC applied median 22 hours/day; trial randomized 2,003 participants.

Zhang et al. meta-analysis (stroke): After stroke, pooled RCTs show IPC significantly reduced incidence of DVT (Zhang et al. 2018 meta-analysis: RR 0.50; 95% CI 0.27-0.94), but increased IPC-related adverse events (RR 5.71).

Seven RCTs, 3,551 participants included in meta-analysis.

Coding (HCPCS & Regulatory Identifiers)

DME / Appliance / Accessory HCPCS and Supply Codes listed for referenceHCPCS

A4600	Sleeve for intermittent limb compression device, replacement only, each
E0650	Pneumatic compressor, nonsegmental home model
E0651	Pneumatic compressor, segmental home model without calibrated gradient pressure
E0652	Pneumatic compressor, segmental home model with calibrated gradient pressure
E0655	Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm
E0658	Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest
E0659	Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest
E0660	Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg
E0665	Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm
E0666	Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg

1–10 of 19

1/2

Regulatory / informational device codesmixed

FDA Class II	Devices and systems to perform pneumatic compression are regulated by FDA as Class II devices (product code JOW).
K203178	FDA clearance document number for Flexitouch Plus System (Tactile Systems Technology, Inc) for head and neck lymphedema (cleared Dec 20, 2020).

HCPCS and other procedure codes are provided in the policy for reference only. Coverage and billing decisions should follow payer‑specific rules, the member’s benefit plan, and the InterQual medical necessity determinations rather than code lists alone.

Provider Actions & Requirements

Documentation Required

Use InterQual clinical criteria for medical necessity determination

When coverage is being considered for pneumatic compression devices, refer to and document fulfillment of the InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices clinical criteria. Include relevant medical records to support that InterQual criteria are met when submitting for coverage review.

Clinical notes documenting diagnosis, severity, and duration of condition
Results of prior conservative therapies (e.g., compression bandaging/garments, wound care) and response
Wound measurements, photographs, or ulcer surface area and healing timeline (for VLU)
Functional assessments and mobility status (for DVT prevention/IPC use)
Device-specific orders and treatment plan (prescription specifying device type, frequency, and duration)

Definitions

Glossary: Pneumatic compression devices — Powered, typically FDA Class II devices that use an air compressor and multi‑chamber garments (e.g., Flexitouch) for prevention of DVT or treatment of lymphedema and chronic wounds.

Revision History

2026-06-01material_revisionLatest

Replaced reference to 'InterQual ® CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices' with 'InterQual ® CP: Durable Medical Equipment, Pneumatic Compression Devices'; revised language pertaining to medical necessity clinical coverage criteria; updated Clinical Evidence and References sections; archived previous policy version 2026T0563W.

2026-06-01non-material_update

References and HTA citations refreshed (including ECRI 2025, European 2024 guideline updates, Hayes annual reviews); Clinical Evidence and References sections updated to reflect current information.

Policy Summary

PayerColorado Rocky Mountain Health Plans

PolicyPneumatic Compression Devices

Policy CodePolicy 2026T0563X

Change TypeRevised medical necessity language; references updated

Effective DateJune 1, 2026

Next Review Date

Key ActionWhen coverage is considered, refer to and document fulfillment of InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices clinical criteria.

On This Page

Knee arthroplasty Hayes HTA summary: In total knee arthroplasty, pneumatic compression may reduce DVT especially when combined with LMWH; pneumatic compression alone is less effective than LMWH alone (Hayes HTA).

Hayes HTA (2018, updated 2023) assessed 16 RCTs.

CLOTS3 trial and HTA (stroke): CLOTS 3 trial: IPC applied to immobile stroke patients reduced DVT risk (absolute reduction 3.6%) and improved survival to 6 months (HR 0.86) but increased skin breaks and did not improve disability.

Multicenter RCT (2,876 participants); mean IPC duration ~11 days.

Domeij-Arverud RCT (Achilles repair): IPC reduces early DVT risk during short-term postoperative immobilization after Achilles tendon repair (Domeij-Arverud RCT), but benefit did not persist after IPC stopped.

Reduced DVT at 2 weeks (21% vs 37%); at 6 weeks no significant difference.

Evidence summary - IPC vs no prophylaxis and combined IPC+pharmacologic: Systematic reviews and ECRI assessments indicate IPC reduces DVT vs no prophylaxis in certain postsurgical and critically ill populations; IPC combined with pharmacologic prophylaxis may reduce VTE vs pharmacologic alone (Cochrane, ECRI summaries).

Evidence quality varies; heterogeneity and risk-of-bias noted across studies.

Guideline Recommendations (summarized conditional coverage implications)

Major society guidance statements relevant to mechanical vs pharmacological prophylaxis (multiple guideline sources):

ASH surgical and medical patient recommendations: ASH: For high bleeding risk surgical patients, mechanical methods may be favored; suggest mechanical prophylaxis over none when pharmacologic not used; suggest IPC over stockings when mechanical is used; suggest combined mechanical+pharmacologic over pharmacologic alone in some patients (2019 surgical; 2018/2022 medical updates).

Conditional recommendations based on low-to-moderate certainty evidence.

NICE NG89 contraindications guidance: NICE NG89: Mechanical prophylaxis (stockings or pneumatic devices) should NOT be used in patients with suspected/proven peripheral arterial disease, peripheral arterial bypass grafting, peripheral neuropathy or sensory impairment, local conditions where mechanical prophylaxis may cause damage (fragile skin, dermatitis, gangrene, recent skin graft), severe leg edema, or major limb deformity preventing correct fit.

Risk-assessment and contraindication checklist per guideline.

European perioperative VTE guidelines (2024): European 2024: Institution-wide protocol recommended; pharmacological prophylaxis generally preferred for low-risk hospitalized patients; IPC suggested when high bleeding risk or contraindication to pharmacologic prophylaxis; IPC plus pharmacologic prophylaxis suggested for very high VTE risk; IPC appears more effective than stockings.

Recommendations graded (various grades reported in guideline).

AAPS (plastic surgery) guideline: AAPS: Recommend using IPC to prevent perioperative VTE events in plastic surgery patients; IPC superior to elastic compression stockings (grade 1B).

Recommendation derived largely from meta-analyses in other surgical specialties.

Evidence snapshot (InterQual + key study summaries)

InterQual referenceMedical necessity criteria delegated to InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices

Head/neck lymphedema evidence summaryMultiple small RCTs and observational studies with limited quality; insufficient evidence to establish efficacy of APCDs for head/neck lymphedema

PAD evidence summaryMixed, low-quality evidence; some RCTs and systematic reviews suggest improved walking distance, wound healing in select CLI patients but insufficient evidence to support high-pressure devices for PAD broadly

VLU / lower-extremity lymphedemaRandomized trials suggest IPC as an adjunct to standard compression may improve ulcer healing rates and time to closure in select hard-to-heal venous ulcers

DVT preventionSystematic reviews and RCTs show IPC reduces DVT vs no prophylaxis in certain postsurgical and immobile stroke populations; combined IPC+pharmacologic prophylaxis may reduce VTE vs pharmacologic alone; results mixed in critically ill patients receiving pharmacologic prophylaxis

Arabi et al.Multisite RCT: adjunctive IPC (≥18 hrs/day; median 22 hrs/day for median 7 days) added to pharmacologic prophylaxis did not reduce proximal DVT (RR 0.93; p=0.74)

Zhang et al.Stroke meta-analysis: IPC reduced DVT incidence (RR 0.50; 95% CI 0.27-0.94) but increased IPC-related adverse events (RR 5.71)

CLOTS3 (Dennis et al.)In immobile stroke patients IPC reduced DVT (8.5% vs 12.1%, absolute reduction 3.6%) and improved 6-month survival (HR 0.86) but increased skin breaks; mean IPC duration ~11 days, up to 30 days

Hayes HTA (knee arthroplasty)Pneumatic compression may reduce DVT when combined with LMWH; pneumatic compression alone less effective than LMWH alone

Prominent trials / reports listedArabi et al. (critically ill RCT), Zhang et al. (stroke meta-analysis), CLOTS3 (Dennis et al.), Hayes HTA assessments

Documentation Required

Assess contraindications per NICE

Before using mechanical prophylaxis, document a patient-specific risk assessment and explicitly document the absence of any contraindications listed by NICE prior to device use.

Suspected or proven peripheral arterial disease (PAD)
Peripheral arterial bypass grafting
Peripheral neuropathy or other causes of sensory impairment
Local conditions where mechanical prophylaxis may cause damage (e.g., fragile skin, dermatitis, gangrene, recent skin graft)
Severe leg edema
Major limb deformity or unusual leg size or shape that prevents a correct fit

Prior Authorization

Policy-level medical necessity language revised

Policy-level medical necessity clinical coverage language was revised effective June 1, 2026. Follow the updated policy language and InterQual-referenced coverage criteria when submitting requests for pneumatic compression devices.

Archived previous policy version: 2026T0563W

Billing Rule

FDA device identification

For informational and regulatory identification, note that pneumatic compression devices and systems are regulated as FDA Class II devices under product code JOW. An example device clearance is the Flexitouch Plus System (K203178).